Furthermore, pretreatment with FGF1 or rFGF4 has been demonstrated to confer protection against LPS-induced ALI by modulating anti-inflammatory and antioxidant pathways [36, 37]. The gene discussed is FGF1; the disease is acute respiratory distress syndrome.